A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...

Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...